Critical IllnessNCT06128655
Developing and Testing a Nurse-Led Technology-Enhanced Family Engagement Program
A study testing Participation in PFCC-IR in people with Critical Illness, run by Rutgers, The State University of New Jersey at 1 site in United States.
Trial summary
Family engagement in care for ICU patients is essential to ensure patient-centered clinical outcomes such as reducing ICU length of stay (LOS) by about a day, and hospital LOS from 3.78 days to 2.29 days. Read more about this study
- Who is it for?
- Ages 18 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Critical Illness
- What is being tested?
- Participation in PFCC-IR
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 29 participants
- Where
- 1 siteUnited States
- Study dates
- 5 Aug 2024to 8 Feb 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- men between 18-80 years old who are willing to participate in NURSE-TECH Family
- women between 18-80 years old who are willing to participate in NURSE-TECH Family
Who cannot join
- men younger than 18 or older than 80 who are not willing to participate in NURSE-TECH Family and are non-English speaking.
- women younger than 18 or older than 80 who are not willing to participate in NURSE-TECH Family and are non-English speaking
Trial locations and contacts
1 site in 1 country.
United States1 site
Cooper University Health Care
Camden, New Jersey, 08102
About this study
Official title: Developing and Testing a Nurse-Led Technology-Enhanced Family Engagement Program (NURSE-TECH-Family) Among Critically Ill Patients in ICU: A Randomized Controlled Trial
Family engagement in care for ICU patients is essential to ensure patient-centered clinical outcomes such as reducing ICU length of stay (LOS) by about a day, and hospital LOS from 3.78 days to 2.29 days. It also lowers patient's stress and anxiety, improves orientation, and detection, lowers the prevalence and duration of delirium; enhances patients' and families' satisfaction and experience with care and helps with patients' recovery. This practice has not been universally implemented due to issues with lack of transportation for family members to the hospital, time conflict with work, and clinicians' fear of engaging family. Family-centered care in the ICU remains an inconsistent practice and an understudied area of nursing science. Family-centered care in the ICU remains an inconsistent practice and an understudied area of nursing science. The purpose of this proposed study is to determine the feasibility of conducting a randomized controlled trial (RCT) to implement and test the impact of a Nurse-Led-Technology-EnhanCed Family Engagement Program (Nurse-TECH-Family) on the primary outcome of ICU LOS, and secondary outcome of reducing stress and improving quality of life and well-being among critically ill patients' families. We propose a pilot two-group RCT to examine the feasibility and preliminary effects of NURSE-TECH-Family program on 30 family members in the ICU. This study will be conducted at the Cooper University Health Care Medical Intensive Care Unit. Prior to conducting the RCT, we will involve a focus group of eight healthcare providers to understand healthcare providers' perceptions of the intervention and the project. The specific aims of this RCT are to (1) Assess the feasibility and acceptability of NURSE-TECH-Family program and obtain data on family stress, mental and physical health symptoms, and quality of life of family members. (2) Provide preliminary data for estimation of the effects of NURSE-TECH-Family program on family stress, mental and physical health symptoms, and quality of life post-program compared to a control group who will receive the current standard care. (3) Explore the effects of NURSE-TECH-Family on LOS and satisfaction based on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores at post-program compared to a control group who will receive the current standard care.
Read the detailed description
Purpose/Specific Aims The overall goal of our research is to test the impact of Nurse-TECH-Family program during patient-and-family-centered interdisciplinary rounds (PFCC-IR) in the ICU. Our central hypothesis is that the use of nurse liaisons who utilize telehealth technology to target the barriers to family-engaged critical care (e.g., transportation, time constraints, work-obligations) would lead to less stress and mental and physical health symptoms, and improved quality of life among family members of patients in critical care.
Research Design We propose a pilot two-group RCT to examine the feasibility and preliminary effects of the NURSE-TECH-Family program on 30 family members in the ICU. This study will be conducted at the Cooper University Health Care Intensive Care Unit. Prior to conducting the RCT, we will involve a focus group of eight healthcare providers to understand healthcare providers' perception of the intervention and the project
- Objectives Aim 1: Assess the feasibility and acceptability of the Nurse-TECH-Family program and obtain data on family stress, mental and physical health symptoms, and the quality of life of family members. Feasibility will be assessed using study accrual, protocol adherence, and retention.
Aim 2: Provide preliminary data for estimating the effects of the Nurse-TECH-Family program on family stress, mental and physical health symptoms, and quality of life at post-program compared to the control group who will receive the current standard care (SC).
Aim 3: Explore the effects of Nurse-TECH-Family on LOS and satisfaction based on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores at post-program compared to a control group who will receive the current standard care.
- Hypotheses / Research Question(s) H1: Feasibility will be determined by >80% adherence to the protocol, and <20% attrition. Acceptability will be demonstrated by 80% of participants reporting intervention satisfaction.
H2: Between-group effect sizes will be used to evaluate intervention efficacy on measures of stress, mental and physical health symptoms, and quality of life.
H3: Between-group effect sizes will be used to evaluate patterns suggesting intervention efficacy on LOS and satisfaction based on HCAHPS scores at post-program compared to a control group who will receive the current standard care. This study is not designed to make conclusions about efficacy without further study.
Study Variables A. Independent Variables, Interventions, or Predictor Variables Intervention: participation in Nurse-TECH-Family during PFCC-IR participation; Control: Standard Care (SC) or no Nurse-TECH-Family during PFCC-IR participation
- Dependent Variables or Outcome Measures Outcome 1: number of days for ICU stay; Outcome 2/Secondary Outcomes: physical symptoms in gastrointestinal, respiratory, neurological, cognitive, sleep, swallowing/voice body system; Outcome 3: mental symptoms (depression, anxiety, and stress)
Study Population The eight (8) healthcare providers will include nurses and physicians between 25-80 years old working in the CCU who are willing to participate in focus group sessions.
Family members:
Inclusion criteria: (1) men and women 18-80 years old who are willing to participate in Nurse-TECH Family.
Exclusion criteria: (1) men and women who are under 18 or over 80 years old who are not willing to participate in Nurse-TECH Family.
Research Procedures This feasibility study will help us provide preliminary data for a bigger study, assess the viability of the research plan, and evaluate the adequacy and practicality of the logistics required for delivering the planned intervention and the application of research methods, rather than looking for significance.
Following consent, 30 participants will be randomly assigned in equal allocation to one of two conditions: 1) participation in Nurse-TECH-Family intervention or 2) standard care (SC). The data manager on this study who is not involved with recruitment will randomly draw a number of 1 or 2 to be given the participant's study number (not name) to randomize the participant. Our research evaluator will not be involved in recruitment or have any contact with participants; they will be blinded to participant randomization and conduct all study procedures where blinding is indicated.
RCT Randomization: Following consent, 30 participants will be randomly assigned in equal allocation to one of two conditions: 1) participation in Nurse-TECH-Family intervention or 2) standard care (SC). The data programmer in this study who is not involved with recruitment will randomly draw a number of 1 or 2 to be given the participant's study number (not name) to randomize the participant. Our research evaluator will not be involved in recruitment or have any contact with participants; they will be blinded to participant randomization and conduct all study procedures where blinding is indicated).
Treatment Conditions: Patient-and-family-centered care interdisciplinary rounds (PFCC-IR) are walking rounds - a key strategy for ensuring that the entire team is involved in the care coordination process and that these interventions take place in a timely manner. It is led by the CCU Attending and consists of other members of the medical team assigned to the CCU such as interns, medical residents, fellows, nurses, nurse managers, and other health care professionals such as respiratory therapists and dietitians. A family member and/or significant other will be present to attend this round if they are present in the CCU. The focus of PFCC-IR is to discuss the patient's present condition and plan of care, expected outcomes of care including prognosis, barriers, and challenges to care, transitions in care, and transfer or discharge plan from CCU.
Participants in the Nurse-TECH Family group are expected to participate daily in PFCC-IR when present in CCU. For family members who are not in the CCU in person, the nurse (PIs) will call or virtually via Webex or Microsoft Teams with them daily after the PFCC-IR. The participants in the control group will get SC.
Data Points Participants will have two to complete study assessment measures: baseline, demographic, and social variables (day 1 when in the study) and post-Nurse-TECH Family (when patients leave the CCU). The research evaluator who will be blinded to the group allocation will collect data.
Feasibility will be assessed by examining study accrual, protocol adherence, and retention.
During Study Data:
Baseline (day 1 when in the study) and post-intervention data (when patients leave the CCU):
Demographic, Social, and Medical Variables will be collected via family member's self-report including age, gender, education level, occupational status, socioeconomic determinants of health, and caregiver.
Physical symptoms. The Symptom Experience Index assesses 20 symptoms that indicate the physiological changes in gastrointestinal, respiratory, neurological, cognitive, sleep, swallowing/voice body system (Cronbach's alpha of 0.85 -0.86).
Mental health symptoms. The 2-item Patient Health Questionnaire screen tool with a sensitivity=100% (specificity=77%, AUC=0.88) will be used to assess depression; The Generalized Anxiety Disorder 2-item screen tool with a sensitivity=86% (specificity=83%, Positive likelihood ratio=5.0) will be used to assess anxiety (Cronbach's greater than .70).
Quality of life (QOL). The Short-Form Health Survey (SF-36), a valid and reliable tool, will be used to assess QOL (24). The SF-36 included 8 subscales: (1) physical functioning; (2) role physical, i.e. role limitations because of physical problems; (3) bodily pain; (4) general health; (5) social functioning; (6) role emotional, i.e. role limitations because of emotional problems; (7) vitality (energy/fatigue); (8) mental health, i.e. psychological distress and psychological well-being.
Socioeconomic determinants. Items to screen for social needs and financial strains in The Accountable Health Communities (AHC) model will be used to assess socioeconomic determinants. Demographic and Health Characteristics. Demographic and health characteristics will be assessed using The Accountable Health Communities (AHC) model to include age, gender, race/ethnicity, employment, education, number of chronic conditions, physical activity, substance use, disability, and income.
Study Duration The study duration for each participant is during the CCU stay (a few days to about a week, and 40-45 minutes for assessment on day 1 and the day the patient leaves the CCU). The study duration for the healthcare providers in the focus group will be 2-3 hours.
Sample Size Justification This is a pilot two-group randomized controlled trial to examine the feasibility and preliminary effects of the Nurse-TECH Family program on 30 family members of critically ill patients in the CCU. We are aiming to consecutively recruit a sample size of 30, 15 in each arm. Assuming an effect size of 30 (15 per group) is needed. Furthermore, with a sample of 24 patients total, we will generate sufficient data to approximate the first and second moments of the data distributions for the second and third outcome measures to plan a well-powered future study of a similar population.
Location: Data collection will occur in Cooper University Health Care (Cooper) CCU.
Timing and Frequency:
Family members: Demographics and baseline data will be collected at Cooper University Health Care (Cooper) on day 1 while the patient is in CCU. Participants will be asked to complete the second assessment when the patient leaves the CCU.
Study Instruments:
Length of stay and satisfaction will be assessed based on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores at post-program.
Physical symptoms. The Symptom Experience Index assesses 20 symptoms that indicate the physiological changes Mental health symptoms. The 2-item Patient Health Questionnaire screen tool with a sensitivity=100% (specificity=77%, AUC=0.88) will be used to assess depression; The Generalized Anxiety Disorder 2-item screen tool with a sensitivity=86% (specificity=83%, Positive likelihood ratio=5.0) will be used to assess anxiety. The 1-item Perceived Stress Scale will be used to assess perceived stress (Cronbach's greater than .70).
Quality of life (QOL). The Short- Form Health Survey (SF-36), a valid and reliable tool, will be used to assess QOL.
Socioeconomic determinants. Items to screen for social needs and financial strains in The Accountable Health Communities (AHC) model will be used to assess socioeconomic determinants.
Data Analysis Aim 1 Analysis. For Aims 1, 2, and 3, Feasibility will be assessed by examining accrual, adherence, and attrition. Accrual will be indicated by meeting the recruitment goal of 30 participants in 12 months. Adherence will be indicated by ensuring stable unit treatment values between the group randomized to the NURSE-TECH Family intervention vs. the control (i.e. no crossover/contamination between groups). Attrition will be indicated by 80% of consented participants completing the study protocol (i.e., remain enrolled and completing questionnaires).
- Conditions
- Critical Illness
- Being tested
- Participation in PFCC-IR
- Medical subject headings
- Critical Illness
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Participation in PFCC-IROther
PFCC-IR with the critical care team is standard practice in ICU but it doesn't usually include family members. The intervention for this study is interdisciplinary patient care rounds that include one family member of the patient.
| Study group | Role | What they receive |
|---|---|---|
| CONTROL GROUP: survey and Standard Care (SC) or no NURSE-TECH-Family during PFCC-IR participation | No intervention | 15 family members |
| EXPERIMENTAL GROUP: participation in NURSE-TECH-Family during PFCC-IR | Experimental | 15 family members Receives: Other: Participation in PFCC-IR |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assessing length of stay (LOS) after Inclusion in PFCC-IR
length of stay
Measured: Post-intervention data (when patients leave the ICU). The data about the number of days in ICU will be assessed upon survey of family members once the patient is discharged from the ICU up to 4 weeks.
Assessing physical symptoms in gastrointestinal, respiratory, neurological, cognitive, sleep, swallowing/voice body system
Numbers of Health Symptoms. The Symptom Experience Index will measure the number of physical symptoms. This instrument assesses 20 symptoms that indicate the physiological changes in gastrointestinal, respiratory, neurological, cognitive, sleep, swallowing/voice body systems. This reliable and valid tool can differentiate healthy individuals from cancer, medical-surgical, and obstetric patients (Cronbach's alpha = 0.85 -0.86). The instrument uses a Likert scale between 0-5 (never, seldom, frequently, usually, always).
Measured: Baseline (day 1 when in the study) and post-intervention data (when patients leave the ICU) up to 4 weeks.
Assessing mental health symptoms: depression
The 2-item Patient Health Questionnaire (PHQ-2) screen tool with a reported sensitivity=100% (specificity=77%, AUC=0.88) will be used to assess depression. The instrument uses a Likert scale between 0-3 (not at all, several days, more than half the days, nearly every day).
Measured: Family members will be surveyed about how often they have been bothered by the symptoms in the last 2 weeks. A post-intervention survey will be administered once the patient leaves the ICU up to 4 weeks
Assessing mental health symptoms: anxiety
Anxiety: The generalized Anxiety Disorder 2-item (GAD-2) screen tool with a reported sensitivity=86% (specificity=83%, Positive likelihood ratio=5.0) will be used to assess anxiety. The instrument uses a Likert scale between 0-3 (not at all, several days, more than half the days, nearly every day).
Measured: Family members will be surveyed about how often they have been bothered by the symptoms in the last 2 weeks. A post-intervention survey will be administered once the patient leaves the ICU up to 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Nov 2023
- Study start5 Aug 2024
- Primary completion8 Feb 2025
- Study completion8 Feb 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (34)Papers the sponsor has linked to this study.
- Other trials for Critical IllnessStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 29 participants (actual)
Sponsor and investigators
- Lead sponsor
- Rutgers, The State University of New Jersey
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Brigitte S. Cypress, EdD, RN, CCRN, Rutgers, The State University of New Jersey
- Investigators
- BRIGITTE S CYPRESS, Principal investigator, RUTGERS SCHOOL OF NURSING CAMDEN
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06128655
- Sponsor's protocol ID
- Pro2023000214
- Other IDs
- Registration No. IORG0000357
- Status last verified
- Mar 2025
- First submitted
- 31 Oct 2023
- Last updated
- 7 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Individual participant data that underlie the results that will be reported in future articles based on this study will be available after deidentification (texts, tables, figures, and appendices)
Publications
Elcokany, N. & Abdel Wareth, M. (2019). Perception of intensive care unit nurses toward family engagement in patients' care. International Journal of Novel Research in Nursing, 6(2), 1099-1110.
Goldfarb MJ, Bechtel C, Capers Q 4th, de Velasco A, Dodson JA, Jackson JL, Kitko L, Pina IL, Rayner-Hartley E, Wenger NK, Gulati M; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular Radiology and Intervention; Council on Hypertension; Council on the Kidney in Cardiovascular Disease; and Council on Lifestyle and Cardiometabolic Health. Engaging Families in Adult Cardiovascular Care: A Scientific Statement From the American Heart Association. J Am Heart Assoc. 2022 May 17;11(10):e025859. doi: 10.1161/JAHA.122.025859. Epub 2022 Apr 21.
PubMed 35446109Lee HW, Park Y, Jang EJ, Lee YJ. Intensive care unit length of stay is reduced by protocolized family support intervention: a systematic review and meta-analysis. Intensive Care Med. 2019 Aug;45(8):1072-1081. doi: 10.1007/s00134-019-05681-3. Epub 2019 Jul 3.
PubMed 31270579Rosa RG, Tonietto TF, da Silva DB, Gutierres FA, Ascoli AM, Madeira LC, Rutzen W, Falavigna M, Robinson CC, Salluh JI, Cavalcanti AB, Azevedo LC, Cremonese RV, Haack TR, Eugenio CS, Dornelles A, Bessel M, Teles JMM, Skrobik Y, Teixeira C; ICU Visits Study Group Investigators. Effectiveness and Safety of an Extended ICU Visitation Model for Delirium Prevention: A Before and After Study. Crit Care Med. 2017 Oct;45(10):1660-1667. doi: 10.1097/CCM.0000000000002588.
PubMed 28671901Jaberi AA, Zamani F, Nadimi AE, Bonabi TN. Effect of family presence during teaching rounds on patient's anxiety and satisfaction in cardiac intensive care unit: A double-blind randomized controlled trial. J Educ Health Promot. 2020 Jan 30;9:22. doi: 10.4103/jehp.jehp_417_19. eCollection 2020.
PubMed 32154317Heydari A, Sharifi M, Moghaddam AB. Family participation in the care of older adult patients admitted to the intensive care unit: A scoping review. Geriatr Nurs. 2020 Jul-Aug;41(4):474-484. doi: 10.1016/j.gerinurse.2020.01.020. Epub 2020 Feb 12.
PubMed 32059826Kleinpell R, Zimmerman J, Vermoch KL, Harmon LA, Vondracek H, Hamilton R, Hanson B, Hwang DY. Promoting Family Engagement in the ICU: Experience From a National Collaborative of 63 ICUs. Crit Care Med. 2019 Dec;47(12):1692-1698. doi: 10.1097/CCM.0000000000004009.
PubMed 31567354Pun BT, Badenes R, Heras La Calle G, Orun OM, Chen W, Raman R, Simpson BK, Wilson-Linville S, Hinojal Olmedillo B, Vallejo de la Cueva A, van der Jagt M, Navarro Casado R, Leal Sanz P, Orhun G, Ferrer Gomez C, Nunez Vazquez K, Pineiro Otero P, Taccone FS, Gallego Curto E, Caricato A, Woien H, Lacave G, O'Neal HR Jr, Peterson SJ, Brummel NE, Girard TD, Ely EW, Pandharipande PP; COVID-19 Intensive Care International Study Group. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Lancet Respir Med. 2021 Mar;9(3):239-250. doi: 10.1016/S2213-2600(20)30552-X. Epub 2021 Jan 8.
PubMed 33428871Kotfis K, Williams Roberson S, Wilson JE, Dabrowski W, Pun BT, Ely EW. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care. 2020 Apr 28;24(1):176. doi: 10.1186/s13054-020-02882-x.
PubMed 32345343Roze des Ordons AL, Au S, Blades K, Stelfox HT. Family participation in ICU rounds-Working toward improvement. J Eval Clin Pract. 2020 Dec;26(6):1620-1628. doi: 10.1111/jep.13345. Epub 2020 Jan 9.
PubMed 31916653Hetland B, McAndrew N, Perazzo J, Hickman R. A qualitative study of factors that influence active family involvement with patient care in the ICU: Survey of critical care nurses. Intensive Crit Care Nurs. 2018 Feb;44:67-75. doi: 10.1016/j.iccn.2017.08.008. Epub 2017 Nov 21.
PubMed 29169879Hwang DY, Zhang Q, Andrews A, LaRose K, Gonzalez M, Harmon L, Vermoch K. The Initial Impact of the Coronavirus Disease 2019 Pandemic on ICU Family Engagement: Lessons Learned From a Collaborative of 27 ICUs. Crit Care Explor. 2021 Apr 2;3(4):e0401. doi: 10.1097/CCE.0000000000000401. eCollection 2021 Apr.
PubMed 33834173Hart JL, Taylor SP. Family Presence for Critically Ill Patients During a Pandemic. Chest. 2021 Aug;160(2):549-557. doi: 10.1016/j.chest.2021.05.003. Epub 2021 May 8.
PubMed 33971149Hamilton R, Kleinpell R, Lipman J, Davidson JE. International facilitators and barriers to family engagement in the ICU: Results of a qualitative analysis. J Crit Care. 2020 Aug;58:72-77. doi: 10.1016/j.jcrc.2020.04.011. Epub 2020 Apr 22.
PubMed 32361221Taylor SP, Short RT 3rd, Asher AM, Taylor B, Beidas RS. A rapid pre-implementation evaluation to inform a family engagement navigator program during COVID-19. Implement Sci Commun. 2020 Dec 9;1(1):110. doi: 10.1186/s43058-020-00098-2.
PubMed 33298192
Study at a glance
From the registry record, last updated by the sponsor on 7 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Developing and Testing a Nurse-Led Technology-Enhanced Family Engagement Program (NURSE-TECH-Family) Among Critically Ill Patients in ICU: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06128655
- Acronym / sponsor ID
- Pro2023000214
- Conditions
- Critical Illness
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 29 participants (actual)
- Lead sponsor
- Rutgers, The State University of New JerseyUniversity, hospital or other
- Study start
- 5 Aug 2024 (actual)
- Primary completion
- 8 Feb 2025 (actual)
- Study completion
- 8 Feb 2025 (actual)
- First posted
- 13 Nov 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Family engagement in care for ICU patients is essential to ensure patient-centered clinical outcomes such as reducing ICU length of stay (LOS) by about a day, and hospital LOS from 3.78 days to 2.29 days. It also lowers patient's stress and anxiety, improves orientation, and detection, lowers the prevalence and duration of delirium; enhances patients' and families' satisfaction and experience with care and helps with patients' recovery. This practice has not been universally implemented due to issues with lack of transportation for family members to the hospital, time conflict with work, and clinicians' fear of engaging family. Family-centered care in the ICU remains an inconsistent practice and an understudied area of nursing science. Family-centered care in the ICU remains an inconsistent practice and an understudied area of nursing science. The purpose of this proposed study is to determine the feasibility of conducting a randomized controlled trial (RCT) to implement and test the impact of a Nurse-Led-Technology-EnhanCed Family Engagement Program (Nurse-TECH-Family) on the primary outcome of ICU LOS, and secondary outcome of reducing stress and improving quality of life and well-being among critically ill patients' families. We propose a pilot two-group RCT to examine the feasibility and preliminary effects of NURSE-TECH-Family program on 30 family members in the ICU. This study will be conducted at the Cooper University Health Care Medical Intensive Care Unit. Prior to conducting the RCT, we will involve a focus group of eight healthcare providers to understand healthcare providers' perceptions of the intervention and the project. The specific aims of this RCT are to (1) Assess the feasibility and acceptability of NURSE-TECH-Family program and obtain data on family stress, mental and physical health symptoms, and quality of life of family members. (2) Provide preliminary data for estimation of the effects of NURSE-TECH-Family program on family stress, mental and physical health symptoms, and quality of life post-program compared to a control group who will receive the current standard care. (3) Explore the effects of NURSE-TECH-Family on LOS and satisfaction based on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores at post-program compared to a control group who will receive the current standard care.
Detailed description
Purpose/Specific Aims The overall goal of our research is to test the impact of Nurse-TECH-Family program during patient-and-family-centered interdisciplinary rounds (PFCC-IR) in the ICU. Our central hypothesis is that the use of nurse liaisons who utilize telehealth technology to target the barriers to family-engaged critical care (e.g., transportation, time constraints, work-obligations) would lead to less stress and mental and physical health symptoms, and improved quality of life among family members of patients in critical care.
Research Design We propose a pilot two-group RCT to examine the feasibility and preliminary effects of the NURSE-TECH-Family program on 30 family members in the ICU. This study will be conducted at the Cooper University Health Care Intensive Care Unit. Prior to conducting the RCT, we will involve a focus group of eight healthcare providers to understand healthcare providers' perception of the intervention and the project
- Objectives Aim 1: Assess the feasibility and acceptability of the Nurse-TECH-Family program and obtain data on family stress, mental and physical health symptoms, and the quality of life of family members. Feasibility will be assessed using study accrual, protocol adherence, and retention.
Aim 2: Provide preliminary data for estimating the effects of the Nurse-TECH-Family program on family stress, mental and physical health symptoms, and quality of life at post-program compared to the control group who will receive the current standard care (SC).
Aim 3: Explore the effects of Nurse-TECH-Family on LOS and satisfaction based on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores at post-program compared to a control group who will receive the current standard care.
- Hypotheses / Research Question(s) H1: Feasibility will be determined by >80% adherence to the protocol, and <20% attrition. Acceptability will be demonstrated by 80% of participants reporting intervention satisfaction.
H2: Between-group effect sizes will be used to evaluate intervention efficacy on measures of stress, mental and physical health symptoms, and quality of life.
H3: Between-group effect sizes will be used to evaluate patterns suggesting intervention efficacy on LOS and satisfaction based on HCAHPS scores at post-program compared to a control group who will receive the current standard care. This study is not designed to make conclusions about efficacy without further study.
Study Variables A. Independent Variables, Interventions, or Predictor Variables Intervention: participation in Nurse-TECH-Family during PFCC-IR participation; Control: Standard Care (SC) or no Nurse-TECH-Family during PFCC-IR participation
- Dependent Variables or Outcome Measures Outcome 1: number of days for ICU stay; Outcome 2/Secondary Outcomes: physical symptoms in gastrointestinal, respiratory, neurological, cognitive, sleep, swallowing/voice body system; Outcome 3: mental symptoms (depression, anxiety, and stress)
Study Population The eight (8) healthcare providers will include nurses and physicians between 25-80 years old working in the CCU who are willing to participate in focus group sessions.
Family members:
Inclusion criteria: (1) men and women 18-80 years old who are willing to participate in Nurse-TECH Family.
Exclusion criteria: (1) men and women who are under 18 or over 80 years old who are not willing to participate in Nurse-TECH Family.
Research Procedures This feasibility study will help us provide preliminary data for a bigger study, assess the viability of the research plan, and evaluate the adequacy and practicality of the logistics required for delivering the planned intervention and the application of research methods, rather than looking for significance.
Following consent, 30 participants will be randomly assigned in equal allocation to one of two conditions: 1) participation in Nurse-TECH-Family intervention or 2) standard care (SC). The data manager on this study who is not involved with recruitment will randomly draw a number of 1 or 2 to be given the participant's study number (not name) to randomize the participant. Our research evaluator will not be involved in recruitment or have any contact with participants; they will be blinded to participant randomization and conduct all study procedures where blinding is indicated.
RCT Randomization: Following consent, 30 participants will be randomly assigned in equal allocation to one of two conditions: 1) participation in Nurse-TECH-Family intervention or 2) standard care (SC). The data programmer in this study who is not involved with recruitment will randomly draw a number of 1 or 2 to be given the participant's study number (not name) to randomize the participant. Our research evaluator will not be involved in recruitment or have any contact with participants; they will be blinded to participant randomization and conduct all study procedures where blinding is indicated).
Treatment Conditions: Patient-and-family-centered care interdisciplinary rounds (PFCC-IR) are walking rounds - a key strategy for ensuring that the entire team is involved in the care coordination process and that these interventions take place in a timely manner. It is led by the CCU Attending and consists of other members of the medical team assigned to the CCU such as interns, medical residents, fellows, nurses, nurse managers, and other health care professionals such as respiratory therapists and dietitians. A family member and/or significant other will be present to attend this round if they are present in the CCU. The focus of PFCC-IR is to discuss the patient's present condition and plan of care, expected outcomes of care including prognosis, barriers, and challenges to care, transitions in care, and transfer or discharge plan from CCU.
Participants in the Nurse-TECH Family group are expected to participate daily in PFCC-IR when present in CCU. For family members who are not in the CCU in person, the nurse (PIs) will call or virtually via Webex or Microsoft Teams with them daily after the PFCC-IR. The participants in the control group will get SC.
Data Points Participants will have two to complete study assessment measures: baseline, demographic, and social variables (day 1 when in the study) and post-Nurse-TECH Family (when patients leave the CCU). The research evaluator who will be blinded to the group allocation will collect data.
Feasibility will be assessed by examining study accrual, protocol adherence, and retention.
During Study Data:
Baseline (day 1 when in the study) and post-intervention data (when patients leave the CCU):
Demographic, Social, and Medical Variables will be collected via family member's self-report including age, gender, education level, occupational status, socioeconomic determinants of health, and caregiver.
Physical symptoms. The Symptom Experience Index assesses 20 symptoms that indicate the physiological changes in gastrointestinal, respiratory, neurological, cognitive, sleep, swallowing/voice body system (Cronbach's alpha of 0.85 -0.86).
Mental health symptoms. The 2-item Patient Health Questionnaire screen tool with a sensitivity=100% (specificity=77%, AUC=0.88) will be used to assess depression; The Generalized Anxiety Disorder 2-item screen tool with a sensitivity=86% (specificity=83%, Positive likelihood ratio=5.0) will be used to assess anxiety (Cronbach's greater than .70).
Quality of life (QOL). The Short-Form Health Survey (SF-36), a valid and reliable tool, will be used to assess QOL (24). The SF-36 included 8 subscales: (1) physical functioning; (2) role physical, i.e. role limitations because of physical problems; (3) bodily pain; (4) general health; (5) social functioning; (6) role emotional, i.e. role limitations because of emotional problems; (7) vitality (energy/fatigue); (8) mental health, i.e. psychological distress and psychological well-being.
Socioeconomic determinants. Items to screen for social needs and financial strains in The Accountable Health Communities (AHC) model will be used to assess socioeconomic determinants. Demographic and Health Characteristics. Demographic and health characteristics will be assessed using The Accountable Health Communities (AHC) model to include age, gender, race/ethnicity, employment, education, number of chronic conditions, physical activity, substance use, disability, and income.
Study Duration The study duration for each participant is during the CCU stay (a few days to about a week, and 40-45 minutes for assessment on day 1 and the day the patient leaves the CCU). The study duration for the healthcare providers in the focus group will be 2-3 hours.
Sample Size Justification This is a pilot two-group randomized controlled trial to examine the feasibility and preliminary effects of the Nurse-TECH Family program on 30 family members of critically ill patients in the CCU. We are aiming to consecutively recruit a sample size of 30, 15 in each arm. Assuming an effect size of 30 (15 per group) is needed. Furthermore, with a sample of 24 patients total, we will generate sufficient data to approximate the first and second moments of the data distributions for the second and third outcome measures to plan a well-powered future study of a similar population.
Location: Data collection will occur in Cooper University Health Care (Cooper) CCU.
Timing and Frequency:
Family members: Demographics and baseline data will be collected at Cooper University Health Care (Cooper) on day 1 while the patient is in CCU. Participants will be asked to complete the second assessment when the patient leaves the CCU.
Study Instruments:
Length of stay and satisfaction will be assessed based on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores at post-program.
Physical symptoms. The Symptom Experience Index assesses 20 symptoms that indicate the physiological changes Mental health symptoms. The 2-item Patient Health Questionnaire screen tool with a sensitivity=100% (specificity=77%, AUC=0.88) will be used to assess depression; The Generalized Anxiety Disorder 2-item screen tool with a sensitivity=86% (specificity=83%, Positive likelihood ratio=5.0) will be used to assess anxiety. The 1-item Perceived Stress Scale will be used to assess perceived stress (Cronbach's greater than .70).
Quality of life (QOL). The Short- Form Health Survey (SF-36), a valid and reliable tool, will be used to assess QOL.
Socioeconomic determinants. Items to screen for social needs and financial strains in The Accountable Health Communities (AHC) model will be used to assess socioeconomic determinants.
Data Analysis Aim 1 Analysis. For Aims 1, 2, and 3, Feasibility will be assessed by examining accrual, adherence, and attrition. Accrual will be indicated by meeting the recruitment goal of 30 participants in 12 months. Adherence will be indicated by ensuring stable unit treatment values between the group randomized to the NURSE-TECH Family intervention vs. the control (i.e. no crossover/contamination between groups). Attrition will be indicated by 80% of consented participants completing the study protocol (i.e., remain enrolled and completing questionnaires).
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| CONTROL GROUP: survey and Standard Care (SC) or no NURSE-TECH-Family during PFCC-IR participation | No intervention | –15 family members |
| EXPERIMENTAL GROUP: participation in NURSE-TECH-Family during PFCC-IR | Experimental | Other: Participation in PFCC-IR15 family members |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- men between 18-80 years old who are willing to participate in NURSE-TECH Family
- women between 18-80 years old who are willing to participate in NURSE-TECH Family
Key exclusion criteria (2 listed)
- men younger than 18 or older than 80 who are not willing to participate in NURSE-TECH Family and are non-English speaking.
- women younger than 18 or older than 80 who are not willing to participate in NURSE-TECH Family and are non-English speaking
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Participation in PFCC-IRPFCC-IR with the critical care team is standard practice in ICU but it doesn't usually include family members. The intervention for this study is interdisciplinary patient care rounds that include one family member of the patient. | Other | EXPERIMENTAL GROUP: participation in NURSE-TECH-Family during PFCC-IR |
Primary outcome
Assessing length of stay (LOS) after Inclusion in PFCC-IR
Time frame: Post-intervention data (when patients leave the ICU). The data about the number of days in ICU will be assessed upon survey of family members once the patient is discharged from the ICU up to 4 weeks.
length of stay
Assessing physical symptoms in gastrointestinal, respiratory, neurological, cognitive, sleep, swallowing/voice body system
Time frame: Baseline (day 1 when in the study) and post-intervention data (when patients leave the ICU) up to 4 weeks.
Numbers of Health Symptoms. The Symptom Experience Index will measure the number of physical symptoms. This instrument assesses 20 symptoms that indicate the physiological changes in gastrointestinal, respiratory, neurological, cognitive, sleep, swallowing/voice body systems. This reliable and valid tool can differentiate healthy individuals from cancer, medical-surgical, and obstetric patients (Cronbach's alpha = 0.85 -0.86). The instrument uses a Likert scale between 0-5 (never, seldom, frequently, usually, always).
Assessing mental health symptoms: depression
Time frame: Family members will be surveyed about how often they have been bothered by the symptoms in the last 2 weeks. A post-intervention survey will be administered once the patient leaves the ICU up to 4 weeks
The 2-item Patient Health Questionnaire (PHQ-2) screen tool with a reported sensitivity=100% (specificity=77%, AUC=0.88) will be used to assess depression. The instrument uses a Likert scale between 0-3 (not at all, several days, more than half the days, nearly every day).
Assessing mental health symptoms: anxiety
Time frame: Family members will be surveyed about how often they have been bothered by the symptoms in the last 2 weeks. A post-intervention survey will be administered once the patient leaves the ICU up to 4 weeks
Anxiety: The generalized Anxiety Disorder 2-item (GAD-2) screen tool with a reported sensitivity=86% (specificity=83%, Positive likelihood ratio=5.0) will be used to assess anxiety. The instrument uses a Likert scale between 0-3 (not at all, several days, more than half the days, nearly every day).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Mar 2025.
- BackgroundElcokany, N. & Abdel Wareth, M. (2019). Perception of intensive care unit nurses toward family engagement in patients' care. International Journal of Novel Research in Nursing, 6(2), 1099-1110.
- Background: PubMed 35446109Goldfarb MJ, Bechtel C, Capers Q 4th, de Velasco A, Dodson JA, Jackson JL, Kitko L, Pina IL, Rayner-Hartley E, Wenger NK, Gulati M; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular Radiology and Intervention; Council on Hypertension; Council on the Kidney in Cardiovascular Disease; and Council on Lifestyle and Cardiometabolic Health. Engaging Families in Adult Cardiovascular Care: A Scientific Statement From the American Heart Association. J Am Heart Assoc. 2022 May 17;11(10):e025859. doi: 10.1161/JAHA.122.025859. Epub 2022 Apr 21.
- Background: PubMed 31270579Lee HW, Park Y, Jang EJ, Lee YJ. Intensive care unit length of stay is reduced by protocolized family support intervention: a systematic review and meta-analysis. Intensive Care Med. 2019 Aug;45(8):1072-1081. doi: 10.1007/s00134-019-05681-3. Epub 2019 Jul 3.
- Background: PubMed 28671901Rosa RG, Tonietto TF, da Silva DB, Gutierres FA, Ascoli AM, Madeira LC, Rutzen W, Falavigna M, Robinson CC, Salluh JI, Cavalcanti AB, Azevedo LC, Cremonese RV, Haack TR, Eugenio CS, Dornelles A, Bessel M, Teles JMM, Skrobik Y, Teixeira C; ICU Visits Study Group Investigators. Effectiveness and Safety of an Extended ICU Visitation Model for Delirium Prevention: A Before and After Study. Crit Care Med. 2017 Oct;45(10):1660-1667. doi: 10.1097/CCM.0000000000002588.
- Background: PubMed 32154317Jaberi AA, Zamani F, Nadimi AE, Bonabi TN. Effect of family presence during teaching rounds on patient's anxiety and satisfaction in cardiac intensive care unit: A double-blind randomized controlled trial. J Educ Health Promot. 2020 Jan 30;9:22. doi: 10.4103/jehp.jehp_417_19. eCollection 2020.
- Background: PubMed 32059826Heydari A, Sharifi M, Moghaddam AB. Family participation in the care of older adult patients admitted to the intensive care unit: A scoping review. Geriatr Nurs. 2020 Jul-Aug;41(4):474-484. doi: 10.1016/j.gerinurse.2020.01.020. Epub 2020 Feb 12.
- Background: PubMed 31567354Kleinpell R, Zimmerman J, Vermoch KL, Harmon LA, Vondracek H, Hamilton R, Hanson B, Hwang DY. Promoting Family Engagement in the ICU: Experience From a National Collaborative of 63 ICUs. Crit Care Med. 2019 Dec;47(12):1692-1698. doi: 10.1097/CCM.0000000000004009.
- Background: PubMed 33428871Pun BT, Badenes R, Heras La Calle G, Orun OM, Chen W, Raman R, Simpson BK, Wilson-Linville S, Hinojal Olmedillo B, Vallejo de la Cueva A, van der Jagt M, Navarro Casado R, Leal Sanz P, Orhun G, Ferrer Gomez C, Nunez Vazquez K, Pineiro Otero P, Taccone FS, Gallego Curto E, Caricato A, Woien H, Lacave G, O'Neal HR Jr, Peterson SJ, Brummel NE, Girard TD, Ely EW, Pandharipande PP; COVID-19 Intensive Care International Study Group. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Lancet Respir Med. 2021 Mar;9(3):239-250. doi: 10.1016/S2213-2600(20)30552-X. Epub 2021 Jan 8.
- Background: PubMed 32345343Kotfis K, Williams Roberson S, Wilson JE, Dabrowski W, Pun BT, Ely EW. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care. 2020 Apr 28;24(1):176. doi: 10.1186/s13054-020-02882-x.
- Background: PubMed 31916653Roze des Ordons AL, Au S, Blades K, Stelfox HT. Family participation in ICU rounds-Working toward improvement. J Eval Clin Pract. 2020 Dec;26(6):1620-1628. doi: 10.1111/jep.13345. Epub 2020 Jan 9.
- Background: PubMed 29169879Hetland B, McAndrew N, Perazzo J, Hickman R. A qualitative study of factors that influence active family involvement with patient care in the ICU: Survey of critical care nurses. Intensive Crit Care Nurs. 2018 Feb;44:67-75. doi: 10.1016/j.iccn.2017.08.008. Epub 2017 Nov 21.
- Background: PubMed 33834173Hwang DY, Zhang Q, Andrews A, LaRose K, Gonzalez M, Harmon L, Vermoch K. The Initial Impact of the Coronavirus Disease 2019 Pandemic on ICU Family Engagement: Lessons Learned From a Collaborative of 27 ICUs. Crit Care Explor. 2021 Apr 2;3(4):e0401. doi: 10.1097/CCE.0000000000000401. eCollection 2021 Apr.
- Individual participant dataSharing planned: Yes. Individual participant data that underlie the results that will be reported in future articles based on this study will be available after deidentification (texts, tables, figures, and appendices)
Related trials for Critical Illness
RecruitingPhase 4
Effect of a Furosemide Stress Test-Guided Strategy on Liberation From Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury
Acute Kidney Injury
Not yet recruiting
Building Resilience Through Anxiety Virtual Education in PICU Survivors
Critical Illness Recovery, Mental Health
Active, not recruiting
PICU Up!: A Pilot Stepped-wedge Trial of a Multicomponent Early Mobility Intervention for Critically Ill Children
Critical Illness
RecruitingPhase 3
A Trial of Adjunctive Fludrocortisone (50mcg, 100mcg or Placebo) in Critically Ill Patients With Septic Shock Receiving Hydrocortisone, Evaluating Survival and Functional Recovery and the Influence of Transcriptomic Response
Septic Shock
Not yet recruiting
Feasibility Study on the Use of a Walking Exoskeleton in the Intensive Care Unit
Neuromuscular Disease in Post-Intensive Care Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
BRIGITTE S CYPRESS principal investigator
RUTGERS SCHOOL OF NURSING CAMDEN
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Participation in PFCC-IR in people with Critical Illness, run by Rutgers, The State University of New Jersey at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assessing length of stay (LOS) after Inclusion in PFCC-IR (time frame: Post-intervention data (when patients leave the ICU). The data about the number of days in ICU will be assessed upon survey of family members once the patient is discharged from the ICU up to 4 weeks.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06128655, which also lists 34 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Mar 2025.